Measles and BCG Vaccines for Mother and Child

Recruiting now · Phase 4 · Has a placebo group

Conditions studied: Vaccine Preventable Disease, Measles, Mother-Infant Interaction, BCG Vaccination Reaction

In brief

In Africa, the mortality from infectious diseases remains high. The investigators have discovered that live vaccines such as the BCG vaccine against tuberculosis and the measles vaccine can strengthen resistance to other infections: they have beneficial "non-specific effects". The investigators have now seen signs that these non-specific effects for children are stronger if their mother has been given the same vaccines. In Africa, BCG vaccine is recommended at birth and measles vaccine at 9 months of age. They are not used beyond childhood. The investigators will randomize 2400 women to BCG vaccine, measles vaccine, or placebo. The investigators will further randomize their children to an extra early measles vaccine or placebo. The investigators will assess which of the resulting six vaccination schedules are best for women's and children's protection against measles, for the child's immune system, and for general health. The project will be the first in the world to investigate the importance of vaccinating women with live vaccines.

Key facts

Study ID
NCT04899765
Run by
Bandim Health Project
People needed
2400
Starts
2021-05-20
Expected to finish
2027-12-31
Last updated by the study team
2024-01-19

Who can join

Age: 15 and older, up to 35. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.